Revenue growth accelerated to 10.0% YoY in Q2 2026 with gross margin expanding to 31.7% from 25.3% in Q2 2024, driving EPS up 47.1% to $0.50.
Concentra Group Holdings Parent, Inc. (CON) annual income statement — 4-year revenue, gross profit & net income history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 |
|---|
| Sales/Revenue | 2.29B | 2.16B | 1.9B | 1.84B | 1.72B |
| Revenue Growth % | 14.02% | 13.85% | 3.38% | 6.59% | - |
| Cost of Goods Sold | 1.62B | 1.55B | 1.37B | 1.33B | 1.32B |
| COGS % of Revenue | - | 71.66% | 72.21% | 72.12% | 76.33% |
| Gross Profit | 670.56M | 613.09M | 527.98M | 512.43M | 408.19M |
| Gross Margin % | 29.31% | 28.34% | 27.79% | 27.88% | 23.67% |
| Gross Profit Growth % | - | 16.12% | 3.03% | 25.54% | - |
| Operating Expenses | 295.75M | -1.47B | 223.21M | 224.8M | 149.98M |
| OpEx % of Revenue | - | -68.16% | 11.75% | 12.23% | 8.7% |
| Selling, General & Admin | 213.41M | 203.31M | 156.32M | 152M | 149.98M |
| SG&A % of Revenue | - | 9.4% | 8.23% | 8.27% | 8.7% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - |
| Other Operating Expenses | 4M | -1.68B | 66.89M | 72.8M | 0 |
| Operating Income | 374.81M | 2.09B | 304.76M | 287.63M | 258.22M |
| Operating Margin % | 16.39% | 96.5% | 16.04% | 15.65% | 14.97% |
| Operating Income Growth % | - | 584.99% | 5.96% | 11.39% | - |
| EBITDA | 454.56M | 2.16B | 371.94M | 360.68M | 331.88M |
| EBITDA Margin % | 19.87% | 100% | 19.57% | 19.62% | 19.25% |
| EBITDA Growth % | 19.11% | 481.65% | 3.12% | 8.68% | - |
| D&A (Non-Cash Add-back) | 79.75M | 75.82M | 67.18M | 73.05M | 73.67M |
| EBIT | 380.02M | 333.07M | 301.09M | 287.1M | 256.54M |
| Net Interest Income | -107.28M | -109.29M | -69.69M | -114.04M | -31.64M |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 107.28M | 109.29M | 69.69M | 114.04M | 31.64M |
| Other Income/Expense | -107.28M | -1.86B | -73.37M | -45M | -33.32M |
| Pretax Income | 267.53M | 223.78M | 231.39M | 242.63M | 224.9M |
| Pretax Margin % | 11.7% | 10.34% | 12.18% | 13.2% | 13.04% |
| Income Tax | 61.93M | 50.98M | 59.5M | 57.89M | 52.65M |
| Effective Tax Rate % | 23.15% | 22.78% | 25.71% | 23.86% | 23.41% |
| Net Income | 198.73M | 172.8M | 166.54M | 179.95M | 166.73M |
| Net Margin % | 8.69% | 7.99% | 8.76% | 9.79% | 9.67% |
| Net Income Growth % | 33.09% | 3.76% | -7.45% | 7.93% | - |
| Net Income (Continuing) | 205.6M | 172.8M | 171.9M | 184.74M | 172.24M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 29.33M | 27.15M | 23.05M | 21.84M | 22.8M |
| EPS (Diluted) | 1.55 | 1.30 | 1.30 | 1.42 | 1.32 |
| EPS Growth % | 31.62% | 0% | -8.45% | 7.58% | - |
| EPS (Basic) | - | 1.39 | 1.30 | 1.42 | 1.32 |
| Diluted Shares Outstanding | 128.17M | 128.17M | 128.13M | 126.59M | 126.59M |
| Basic Shares Outstanding | 126.65M | 126.65M | 128.13M | 126.59M | 126.59M |
| Dividend Payout Ratio | - | 18.56% | 926.87% | 3.41% | - |
Quick answers to the most common questions about buying CON stock.
For fiscal year 2025, Concentra Group Holdings Parent, Inc. (CON) reported total revenue of $2.16B. This represents a 25.5% increase compared to $1.72B in 2022.
Concentra Group Holdings Parent, Inc. (CON) is profitable, generating $172.8M in net income for the fiscal year ending 2025 with a net profit margin of 8.0%.
Concentra Group Holdings Parent, Inc. (CON) reported an operating income of $2.09B, resulting in an operating profit margin of 96.5%. This margin reflects the operational efficiency of the business before interest and taxes.
Concentra Group Holdings Parent, Inc. (CON) generated $613.1M in gross profit for the year, representing a gross profit margin of 28.3%. This demonstrates the company's core pricing power and production efficiency.
Key Metrics
Top Statement Risk
Elevated leverage and CEO transition
Metrics are mathematically derived from official filings.
Accelerating Revenue Momentum
Revenue grew 10.0% year-over-year in Q2 2026 to $606.0M, accelerating from 5.5% in Q4 2024, according to the latest quarterly report.
The sequential acceleration from 5.5% in Q4 2024 to 10.0% in Q2 2026 suggests strengthening demand in occupational health services, likely tied to robust employment in blue-collar sectors. The consistent quarterly revenue increases, from $465.0M in Q4 2024 to $606.0M in Q2 2026, indicate a durable growth trajectory. Investors should monitor whether this pace is sustainable given potential cyclicality in industrial employment.
Gross Margin Expansion Amid Cost Pressures
Gross margin improved to 31.7% in Q2 2026 from 25.3% in Q2 2024, as reported in financial statements, despite ongoing clinical labor cost inflation.
The 640 basis point expansion in gross margin over eight quarters suggests effective cost management or favorable payer mix, though the 28.34% average gross margin remains below peers like AMSF. The improvement may reflect operational efficiencies and scale benefits, but the sustainability is uncertain given fixed reimbursement rates and potential wage inflation. The recent earnings beat indicates that current cost pressures are manageable, but investors should watch for margin compression if labor costs escalate.
Operating Leverage Driving Profitability
Operating income grew 28.6% year-over-year in Q2 2026 to $115.1M, outpacing revenue growth of 10.0%, as per the income statement data.
The operating margin expanded from 16.3% in Q2 2025 to 19.0% in Q2 2026, indicating that SG&A costs are scaling slower than revenue. SG&A as a percentage of revenue declined from 9.6% to 9.4% over the same period, suggesting disciplined overhead control. This operating leverage appears to be a key driver of the earnings beat, but it may be partly due to one-time items, given the anomalous 96.5% operating margin in the broader data.
Earnings Quality Supported by Low SBC
Net income rose to $65.3M in Q2 2026 with EPS of $0.50, while stock-based compensation was only $4.1M, based on the latest quarterly figures.
The low SBC relative to net income (6.3%) suggests that reported earnings are not significantly diluted by non-cash compensation, enhancing earnings quality. However, the net margin of 10.8% is below the peer average, and the tax rate appears stable. The absence of R&D expenses is typical for a service provider, but investors should note the potential for one-time gains or adjustments in the carve-out financials.
COGS Dominates Cost Structure
COGS accounted for 68.3% of revenue in Q2 2026, totaling $413.9M, as reported in the income statement, reflecting high clinical labor costs.
The cost structure is heavily weighted toward COGS, which includes clinical salaries and facility costs, leaving limited room for cost reduction without impacting service quality. SG&A is relatively lean at 9.4% of revenue, indicating efficient overhead management. The recent gross margin improvement suggests that management has been able to control COGS growth, but the reliance on labor makes the model sensitive to wage inflation.
Q2 2026 Marks Operational Inflection
Q2 2026 showed a significant inflection with EPS of $0.50 versus $0.34 in Q2 2025, a 47.1% increase, according to the quarterly earnings data.
This quarter represents a clear inflection point, with revenue, operating income, and net income all reaching multi-quarter highs. The 47.1% EPS growth, driven by both revenue acceleration and margin expansion, suggests that the company is benefiting from operational leverage and possibly favorable one-time items. The raised guidance following this beat indicates management's confidence in sustained momentum, but the CEO transition introduces uncertainty about future execution.
Leverage and Leadership Risks
Despite strong Q2 2026 results, debt-to-equity stands at 5.0x, and the CEO departure introduces leadership uncertainty, as noted in recent disclosures.
The elevated leverage, while manageable given robust cash flow, could amplify financial risk if operational performance falters. The CEO transition after a decade of leadership may lead to strategic shifts or loss of operational discipline, which could impact the recent margin improvements. Additionally, the anomalous 96.5% operating margin in the data suggests potential reporting artifacts that may overstate underlying profitability, warranting caution in extrapolating current trends.